Thiazolidinediones (TZDs) that act through the nuclear receptor peroxisome proliferator-activated receptor-γ (PPARγ) are potent insulin sensitizers and highly effective oral medications for T2D. The gene discussed is INS; the disease is type 2 diabetes mellitus.